Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Alpha-1 Antitrypsin for BOS Prevention in Lung Transplant
NCT01394835Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of alpha-1-proteinase inhibitor in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01394835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394835.